NextCure, Inc.NXTCNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P25
Within normal range
vs 3Y Ago
-3.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-20.19%
202423.26%
20233.94%
20226.04%
2021-14.43%
2020-33.57%
2019-891.11%
2018123.29%
20170.00%